More articles from Commentary
- Diversifying medical humanities: The case for Jay-Z
Physicians carry considerable power in the patient-physician relationship. Opening our minds to the viewpoints of others diffuses some of that power and grounds us in the communities we serve.
- Appendicitis management: Is it time for a change?
Antibiotic therapy has been a successful alternative to surgery for more than 60 years, but surgery is still the primary treatment.
- The underappreciated role of documentation in improving COPD care
Despite the importance of providing guideline-concordant care, there are still barriers to implementing evidence-based recommendations in providing care for patients with chronic obstructive pulmonary disease.
- Peyronie disease and erectile dysfunction: A potential new paradigm
Viewing Peyronie disease as related to erectile dysfunction allows for the possibility of preventing the disease in patients with erectile insufficiency.
- SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.
Another influenza season in the shadow of the COVID-19 pandemicFlu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.
- Teriparatide: Label changes and identifying patients for long-term use
The changes leave clinicians with the challenge of identifying appropriate patients.
- Statin intolerance and new lipid-lowering treatments
The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.
- What is causing the ‘long-hauler’ phenomenon after COVID-19?
We are still early in our understanding of COVID-19 and its many manifestations.
- Our evolving understanding of primary aldosteronism
Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.